Literature DB >> 35579844

Unsolved issues in treatment for grey zone chronic hepatitis B patients.

Wen-Juei Jeng1,2, Rong-Nan Chien3,4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35579844     DOI: 10.1007/s12072-022-10325-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   9.029


× No keyword cloud information.
  5 in total

1.  Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.

Authors:  Filippo Oliveri; Lidia Surace; Daniela Cavallone; Piero Colombatto; Gabriele Ricco; Nicola Salvati; Barbara Coco; Veronica Romagnoli; Riccardo Gattai; Antonio Salvati; Francesco Moriconi; Quan Yuan; Ferruccio Bonino; Maurizia R Brunetto
Journal:  Liver Int       Date:  2017-04-18       Impact factor: 5.828

Review 2.  Should Treatment Indications for Chronic Hepatitis B Be Expanded?

Authors:  Wen-Juei Jeng; Anna S Lok
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 11.382

3.  Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population.

Authors:  Takashi Kumada; Hidenori Toyoda; Satoshi Yasuda; Takanori Ito; Junko Tanaka
Journal:  Hepatol Res       Date:  2021-11-03       Impact factor: 4.288

4.  Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.

Authors:  Ting-Tsung Chang; Hwai-I Yang; Cheng-Yuan Peng; Chien-Wei Su; Wei Teng; Tung-Hung Su; Tsung-Hui Hu; Ming-Lung Yu; Hung-Chih Yang; Jaw-Ching Wu
Journal:  Hepatol Int       Date:  2021-11-06       Impact factor: 9.029

5.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.